Article metrics

Download PDFPDF

Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2022

AbstractFullPdf
Dec 2019220
Jan 2020550
Feb 202014142
Mar 202011111
Apr 202018182
May 202023233
Jun 202011111
Jul 202015154
Aug 2020773
Sep 202024245
Oct 202027277
Nov 202014146
Dec 202011114
Jan 202113132
Feb 2021882
Mar 202113130
Apr 202113133
May 202117175
Jun 202118180
Jul 202123230
Aug 202119196
Sep 202136369
Oct 202128284
Nov 202120203
Dec 202129308
Jan 202254562
Feb 202234373
Mar 202229293
Apr 202229308
May 202237415
Jun 202243432
Jul 202226317
Total671687110